212 related articles for article (PubMed ID: 37433968)
1. Mutated Toll-like receptor 9 increases Alzheimer's disease risk by compromising innate immunity protection.
Cacace R; Zhou L; Hendrickx Van de Craen E; Buist A; Hoogmartens J; Sieben A; Cras P; Vandenberghe R; De Deyn PP; Oehlrich D; De Bondt A; Engelborghs S; Moechars D; Van Broeckhoven C
Mol Psychiatry; 2023 Dec; 28(12):5380-5389. PubMed ID: 37433968
[TBL] [Abstract][Full Text] [Related]
2. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
[TBL] [Abstract][Full Text] [Related]
3. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
4. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
[TBL] [Abstract][Full Text] [Related]
5. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.
Butchi NB; Du M; Peterson KE
Glia; 2010 Apr; 58(6):650-64. PubMed ID: 19998480
[TBL] [Abstract][Full Text] [Related]
6. Innate Immunity Fights Alzheimer's Disease.
Guillot-Sestier MV; Doty KR; Town T
Trends Neurosci; 2015 Nov; 38(11):674-681. PubMed ID: 26549882
[TBL] [Abstract][Full Text] [Related]
7. Role of toll-like receptor signalling in Abeta uptake and clearance.
Tahara K; Kim HD; Jin JJ; Maxwell JA; Li L; Fukuchi K
Brain; 2006 Nov; 129(Pt 11):3006-19. PubMed ID: 16984903
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease.
Jin JJ; Kim HD; Maxwell JA; Li L; Fukuchi K
J Neuroinflammation; 2008 May; 5():23. PubMed ID: 18510752
[TBL] [Abstract][Full Text] [Related]
9. Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease.
Fiala M; Cribbs DH; Rosenthal M; Bernard G
J Alzheimers Dis; 2007 Jul; 11(4):457-63. PubMed ID: 17656824
[TBL] [Abstract][Full Text] [Related]
10. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Aβ42 phagocytosis.
Li X; Melief E; Postupna N; Montine KS; Keene CD; Montine TJ
Am J Pathol; 2015 Jan; 185(1):230-9. PubMed ID: 25452117
[TBL] [Abstract][Full Text] [Related]
12. LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways.
Yang L; Liu CC; Zheng H; Kanekiyo T; Atagi Y; Jia L; Wang D; N'songo A; Can D; Xu H; Chen XF; Bu G
J Neuroinflammation; 2016 Dec; 13(1):304. PubMed ID: 27931217
[TBL] [Abstract][Full Text] [Related]
13. Innate immune responses after stimulation with Toll-like receptor agonists in ex vivo microglial cultures and an in vivo model using mice with reduced microglia.
Carroll JA; Race B; Williams K; Striebel JF; Chesebro B
J Neuroinflammation; 2021 Sep; 18(1):194. PubMed ID: 34488805
[TBL] [Abstract][Full Text] [Related]
14. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
Yang J; Wise L; Fukuchi KI
Front Immunol; 2020; 11():724. PubMed ID: 32391019
[TBL] [Abstract][Full Text] [Related]
15. Toll-Like Receptor-9 (TLR9) is Requisite for Acute Inflammatory Response and Injury Following Lung Contusion.
Suresh MV; Thomas B; Dolgachev VA; Sherman MA; Goldberg R; Johnson M; Chowdhury A; Machado-Aranda D; Raghavendran K
Shock; 2016 Oct; 46(4):412-9. PubMed ID: 26939039
[TBL] [Abstract][Full Text] [Related]
16. Microglial Activation and Priming in Alzheimer's Disease: State of the Art and Future Perspectives.
Bivona G; Iemmolo M; Agnello L; Lo Sasso B; Gambino CM; Giglio RV; Scazzone C; Ghersi G; Ciaccio M
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614325
[TBL] [Abstract][Full Text] [Related]
17. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
[TBL] [Abstract][Full Text] [Related]
18. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
[TBL] [Abstract][Full Text] [Related]
19. Nucleic Acid-Sensing Toll-Like Receptors Play a Dominant Role in Innate Immune Recognition of Pneumococci.
Famà A; Midiri A; Mancuso G; Biondo C; Lentini G; Galbo R; Giardina MM; De Gaetano GV; Romeo L; Teti G; Beninati C
mBio; 2020 Mar; 11(2):. PubMed ID: 32209688
[No Abstract] [Full Text] [Related]
20. Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
La Rosa F; Saresella M; Baglio F; Piancone F; Marventano I; Calabrese E; Nemni R; Ripamonti E; Cabinio M; Clerici M
Sci Rep; 2017 Dec; 7(1):16760. PubMed ID: 29196629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
